This HTML5 document contains 130 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n12	http://dx.doi.org/10.1200/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n9	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q54373489

rdf:type

wikibase:Item

schema:description

article scientifique 2014年学术文章 научни чланак videnskabelig artikel научная статья 2014年學術文章 2014年學術文章 2014年の論文 bilimsel makale naučni članak articol științific vedecký článok научни чланак wetenschappelijk artikel 2014 nî lūn-bûn 2014년 논문 επιστημονικό άρθρο artigo científico 2014年学术文章 vědecký článek სამეცნიერო სტატია ৩ মার্চ ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ scientific article published on 3 March 2014 tieteellinen artikkeli artigo científico 2014年學術文章 מאמר מדעי teaduslik artikkel 2014年学术文章 artykuł naukowy 2014年学术文章 vetenskaplig artikel artikull shkencor vitenskapelig artikkel scientific article published on 3 March 2014 مقالة علمية نشرت في 3 مارس 2014 2014 թվականի մարտի 3-ին հրատարակված գիտական հոդված наукова стаття, опублікована в березні 2014 article científic artigo científico 2014年学术文章 articolo scientifico научна статия article scientific vitskapeleg artikkel บทความทางวิทยาศาสตร์ scientific article published on 3 March 2014 artikel ilmiah 2014年學術文章 wissenschaftlicher Artikel artículo científico publicado en 2014 tudományos cikk artículu científicu 2014年学术文章 bài báo khoa học мақолаи илмӣ scienca artikolo artikulong pang-agham 2014年學術文章

p:P577

wds:Q54373489-D08BECB9-00A8-4F2D-B2CC-52AC422648D7

wdt:P577

2014-03-03T00:00:00Z

p:P407

wds:Q54373489-DB0089E5-4B22-462F-96B1-DB607F6B350B

wdt:P407

wd:Q1860

p:P2093

wds:Q54373489-EDB87B3D-8403-4372-944A-1FA8F3E952DD wds:Q54373489-ED4BF073-2BB7-4D31-B769-D76E12A49BBA wds:Q54373489-E59A1E69-3BA8-4BEC-B0CD-77CDC1870399 wds:Q54373489-E885E1B2-9852-4FAD-97A4-6763CC26698A wds:Q54373489-C6D904ED-0268-49CB-BAAD-1B9BD2A6E505 wds:Q54373489-C0133280-C124-489A-89B0-A6BA8F1189FA wds:Q54373489-A9E30375-BBD6-4340-B963-E95B6EEFCA36 wds:Q54373489-8A5963D4-FCDA-4088-9A83-8E460E6BA84B wds:Q54373489-877FAF7F-C6AA-4B85-8362-63BC560998E8 wds:Q54373489-89B30734-E716-46EC-9106-5FAC0B7E0DA1 wds:Q54373489-81BE4DB4-C3C0-44C9-8B0D-B3D7631317B1 wds:Q54373489-57D3214A-4986-406A-BE6D-60D1061FA9A1 wds:Q54373489-609E7C9C-AA4D-4547-AEF6-39167B1FCBAF wds:Q54373489-2E158CDC-940F-4D95-8DC7-DA99341D95D4 wds:Q54373489-06E4F0E0-3035-4504-8FB6-1818639562DD wds:Q54373489-1A763E39-3F73-4931-8389-BAB359D31CE4

wdt:P2093

Enrica Roncaglia Katia Cagossi Simona Nuzzo Daniele Giulio Generali Corrado Boni Fabrizio Artioli Luigi Cavanna Catherine Ellis Valentina Guarneri Clare Holford Alberto Bottini Antonio Frassoldati Pierfranco Conte Ramona Swaby Giancarlo Bisagni Guido Ficarra

rdfs:label

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer. Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

skos:prefLabel

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer. Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

schema:name

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer. Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

p:P50

wds:Q54373489-C72CB546-EF36-4209-949C-C56949F0C775 wds:Q54373489-F91D7702-5D23-4B2B-9251-F2309F3478C8 wds:Q54373489-577AE4BA-734D-4E44-86A1-D00E36B9F848 wds:Q54373489-9297ECBA-5F63-4A38-8230-E7DB8D677E2E

wdt:P50

wd:Q51702925 wd:Q53072094 wd:Q37839869 wd:Q51702921

p:P1476

wds:Q54373489-3CE094FF-74EA-4991-A082-6051110D8643

wdt:P1476

Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer.

p:P304

wds:Q54373489-80D1A2D0-5033-47DD-B43A-97BFFF17135A

wdt:P304

1050-1057

p:P31

wds:Q54373489-C5A4FDD6-7261-4101-9209-A011B8A0707D

wdt:P31

wd:Q13442814

p:P921

wds:Q54373489-93954CCF-64A4-45B7-BA51-1C0972383F21

wdt:P921

wd:Q269829

p:P698

wds:Q54373489-4C8520BB-6EE9-4EDF-9003-B1CF67E341DC

wdtn:P698

n9:24590635

wdt:P698

24590635

p:P1433

wds:Q54373489-215CA3D5-04B4-468F-9664-388F81E9C665

wdt:P1433

wd:Q400292

p:P433

wds:Q54373489-2A259C6F-BF1C-4914-8E83-D73A6B5CF22F

p:P478

wds:Q54373489-EBE13BB7-35E6-431E-88C3-0C88E5570417

wdt:P433

10

wdt:P478

32

p:P356

wds:Q54373489-FEA58BB3-0DB3-4178-94F5-2776A1126998

wdtn:P356

n12:JCO.2013.51.4737

wdt:P356

10.1200/JCO.2013.51.4737